Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: Pathway inference in pharmacogenetics

Pharmacogenetics and Genomics

Volumn 17, Issue 4, 2007, Pages 291-294

  Huang, Shuwen ^a   Chen, Xiao He ^b   Payne, John R ^c   Pennell, Dudley J ^d   Gohlke, Peter ^e   Smith, Matt J ^a   Day, Ian N M ^f   Montgomery, Hugh E ^c   Gaunt, Tom R ^f  

^a SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Angiotensin I converting enzyme; BglII B; CSH1.01; Growth hormone; Insertion deletion; Left ventricular mass

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GROWTH HORMONE;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; TRAINING;

ADULT; GENOTYPE; GREAT BRITAIN; HAPLOTYPES; HUMAN GROWTH HORMONE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINKAGE DISEQUILIBRIUM; MALE; MILITARY PERSONNEL; PEPTIDYL-DIPEPTIDASE A; PHARMACOGENETICS; PHYSICAL FITNESS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34247592293     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/01.fpc.0000239976.54217.ac     Document Type: Article

References (11)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
2. Cambien F, Leger J, Mallet C, Levy-Marchal C, Collin D, Czernichow P, et al. Angiotensin I-converting enzyme gene polymorphism modulates the consequences of in utero growth retardation on plasma insulin in young adults. Diabetes 1998; 47:470-475.
3. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90:669-676.
4. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96:741-747.
5. Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000; 11:416-420.
6. Day IN, Chen XH, Gaunt TR, King TH, Voropanov A, Ye S, et al. Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster. J Clin Endocrinol Metab 2004; 89:5569-5576.
7. Unger T, Schüll B, Rascher W, Lang RE, Ganten D. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem Pharmacol 1982; 31:3063-3070.
8. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006; 8:417-426.
9. O'Dell SD, Humphries SE, Day IN. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 1995; 73:368-371.
10. Zhao JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004; 20:1325-1326.
11. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG, et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53:79-91.